Joel J. Adamson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joel J. Adamson has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Joseph Biederman
10 shared publications- Stephen V. Faraone
Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, SUNY Upstate Medical University, Syracuse, USA
6 shared publications - Timothy E. Wilens
Division of Child and Adolescent Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
5 shared publications Michael C. Monuteaux
Massachusetts General Hospital, Pediatric Psychopharmacology Unit, Boston, MA 02114, USA
4 shared publicationsStephanie Sgambati
B Department of Child and Adolescent Pyschiatry, Massachusetts General Hospital, Boston, MA, USA
4 shared publicationsAlison Santry
Massachusetts General Hospital, Pediatric Psychopharmacology Unit, Boston, MA 02114, USA
3 shared publications
Latest Publications
- 28 July 2009
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 70 (11) , 1523-1529
Association Between Attention-Deficit/Hyperactivity Disorder and Sleep Impairment in Adulthood
From The Journal of Clinical Psychiatry:
- 28 July 2009
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 70 (11) , 1523-1529
Association Between Attention-Deficit/Hyperactivity Disorder and Sleep Impairment in Adulthood
From The Journal of Clinical Psychiatry:
- 25 February 2009
- Published by Wiley in Bipolar Disorders
- Vol. 11 (2) , 198-204
Posttraumatic stress disorder and substance use disorder in adolescent bipolar disorder
Objective: Anxiety disorders such as posttraumatic stress disorder (PTSD) and substance use disorders (SUD) are increasingly recognized as comorbid disorders in children with bipolar disorder (BPD). This study explores the relationship between BPD, PTSD, and SUD in a cohort of BPD and non‐BPD adolescents.Methods: We studied 105 adolescents with BPD and 98 non‐mood‐disordered adolescent controls. Psychiatric assessments were made using the Kiddie Schedule for Affective Disorders and Schizophrenia–Epidemiologic Version (KSADS‐E), or Structured Clinical Interview for DSM‐IV (SCID) if 18 years or older. SUD was assessed by KSADS Substance Use module for subjects under 18 years, or SCID module for SUD if age 18 or older.Results: Nine (8%) BPD subjects endorsed PTSD and nine (8%) BPD subjects endorsed subthreshold PTSD compared to one (1%) control subject endorsing full PTSD and two (2%) controls endorsing subthreshold PTSD. Within BPD subjects endorsing PTSD, seven (39%) met criteria for SUD. Significantly more SUD was reported with full PTSD than with subthreshold PTSD (χ2 = 5.58, p = 0.02) or no PTSD (χ2 = 6.45, p = 0.01). Within SUD, the order of onset was BPD, PTSD, and SUD in three cases, while in two cases the order was PTSD, BPD, SUD. The remaining two cases experienced coincident onset of BPD and SUD, which then led to trauma, after which they developed PTSD and worsening SUD.Conclusion: An increased rate of PTSD was found in adolescents with BPD. Subjects with both PTSD and BPD developed significantly more subsequent SUD, with BPD, PTSD, then SUD being the most common order of onset. Follow‐up studies need to be conducted to elucidate the course and causal relationship of BPD, PTSD and SUD.
- 25 February 2009
- Published by Wiley in Bipolar Disorders
- Vol. 11 (2) , 198-204
Posttraumatic stress disorder and substance use disorder in adolescent bipolar disorder
Objective: Anxiety disorders such as posttraumatic stress disorder (PTSD) and substance use disorders (SUD) are increasingly recognized as comorbid disorders in children with bipolar disorder (BPD). This study explores the relationship between BPD, PTSD, and SUD in a cohort of BPD and non‐BPD adolescents.Methods: We studied 105 adolescents with BPD and 98 non‐mood‐disordered adolescent controls. Psychiatric assessments were made using the Kiddie Schedule for Affective Disorders and Schizophrenia–Epidemiologic Version (KSADS‐E), or Structured Clinical Interview for DSM‐IV (SCID) if 18 years or older. SUD was assessed by KSADS Substance Use module for subjects under 18 years, or SCID module for SUD if age 18 or older.Results: Nine (8%) BPD subjects endorsed PTSD and nine (8%) BPD subjects endorsed subthreshold PTSD compared to one (1%) control subject endorsing full PTSD and two (2%) controls endorsing subthreshold PTSD. Within BPD subjects endorsing PTSD, seven (39%) met criteria for SUD. Significantly more SUD was reported with full PTSD than with subthreshold PTSD (χ2 = 5.58, p = 0.02) or no PTSD (χ2 = 6.45, p = 0.01). Within SUD, the order of onset was BPD, PTSD, and SUD in three cases, while in two cases the order was PTSD, BPD, SUD. The remaining two cases experienced coincident onset of BPD and SUD, which then led to trauma, after which they developed PTSD and worsening SUD.Conclusion: An increased rate of PTSD was found in adolescents with BPD. Subjects with both PTSD and BPD developed significantly more subsequent SUD, with BPD, PTSD, then SUD being the most common order of onset. Follow‐up studies need to be conducted to elucidate the course and causal relationship of BPD, PTSD and SUD.
- 12 November 2008
- Published by Wiley in The American Journal on Addictions
- Vol. 17 (6) , 491-496
Concordance between Cigarette Smoking and the Modified Fagerström Tolerance Questionnaire in Controlled Studies of ADHD
Our objective was to compare scores on a smoking questionnaire to a diagnosis of cigarette smoking. As part of follow‐ups in studies of ADHD, we assessed for cigarette smoking using structured interviews and the modified Fagerström Tolerance Questionnaire (mFTQ). Data were obtained from 162 subjects (mean = 19.2 yrs). ROC analysis and kappa coefficients revealed that a cutoff score of 3 on the mFTQ showed the strongest agreement with a full diagnosis of cigarette smoking (kappa = 0.68). Clinicians and researchers using the mFTQ in adolescents and young adults should consider a cutoff score of 3 to be indicative of cigarette smoking.
- 12 November 2008
- Published by Wiley in The American Journal on Addictions
- Vol. 17 (6) , 491-496
Concordance between Cigarette Smoking and the Modified Fagerström Tolerance Questionnaire in Controlled Studies of ADHD
Our objective was to compare scores on a smoking questionnaire to a diagnosis of cigarette smoking. As part of follow‐ups in studies of ADHD, we assessed for cigarette smoking using structured interviews and the modified Fagerström Tolerance Questionnaire (mFTQ). Data were obtained from 162 subjects (mean = 19.2 yrs). ROC analysis and kappa coefficients revealed that a cutoff score of 3 on the mFTQ showed the strongest agreement with a full diagnosis of cigarette smoking (kappa = 0.68). Clinicians and researchers using the mFTQ in adolescents and young adults should consider a cutoff score of 3 to be indicative of cigarette smoking.
- 1 September 2008
- Published by Elsevier in The Journal of Pediatrics
- Vol. 153 (3) , 414-419.e1
Cigarette Smoking Associated with Attention Deficit Hyperactivity Disorder
- 1 September 2008
- Published by Elsevier in The Journal of Pediatrics
- Vol. 153 (3) , 414-419.e1
Cigarette Smoking Associated with Attention Deficit Hyperactivity Disorder
- 1 June 2008
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 95 (3) , 188-198
Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: A controlled study
- 1 June 2008
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 95 (3) , 188-198
Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: A controlled study
- 1 January 2008
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 92 (1-3) , 100-107
Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders
- 1 January 2008
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 92 (1-3) , 100-107
Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders
- 1 July 2007
- Published by Elsevier in Biological Psychiatry
- Vol. 62 (2) , 129-134
Association of Bipolar and Substance Use Disorders in Parents of Adolescents With Bipolar Disorder
- 1 July 2007
- Published by Elsevier in Biological Psychiatry
- Vol. 62 (2) , 129-134
Association of Bipolar and Substance Use Disorders in Parents of Adolescents With Bipolar Disorder
- Open Access
- 1 May 2007
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 88 (2-3) , 244-250
Deriving phenotypes for molecular genetic studies of substance use disorders: A family study approach
- 1 May 2007
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 88 (2-3) , 244-250
Open AccessDeriving phenotypes for molecular genetic studies of substance use disorders: A family study approach
- 12 March 2007
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 37 (12) , 1743-1752
A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults
Background: Studies of adults with attention deficit hyperactivity disorder (ADHD) show an elevated prevalence of substance use disorders (SUDs) and the substance abuse literature shows that ADHD is elevated in substance users. Some researchers postulate that stimulant treatment of ADHD increases the risk for SUD in ADHD patients but follow-up studies suggest treatment protects patients from subsequent SUDs. This report uses retrospective data to assess the impact of prior ADHD pharmacotherapy on SUDs in 206 ADHD adults (n=79 late-onset ADHD, n=127 full ADHD) grouped by lifetime history of ADHD treatment (no treatment, past treatment, current and past treatment).Method: Structured Clinical Interview for DSM-IV (SCID) data were used to establish abuse and dependence, and Drug Use Screening Inventory (DUSI) responses were used to establish prevalence of use, preference for cigarettes, alcohol and drugs of abuse, complications from use, and motivation for use (get high, change mood, sleep better).Results: No differences were found in the prevalence of cigarette smoking, alcohol or drug abuse or dependence, as well as no significant differences in 1-month prevalence of any use or use more than 20 times. No differences were found in complications of drug or alcohol use across groups. Subjects with current treatment rated getting high as a motivating factor significantly more frequently than subjects in the past treatment group; this result lost significance when we included ADHD diagnostic category.Conclusions: Our results are consistent across substances and ADHD diagnoses, and support the hypothesis that pharmacotherapy does not cause subsequent SUDs.
- 12 March 2007
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 37 (12) , 1743-1752
A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults
Background: Studies of adults with attention deficit hyperactivity disorder (ADHD) show an elevated prevalence of substance use disorders (SUDs) and the substance abuse literature shows that ADHD is elevated in substance users. Some researchers postulate that stimulant treatment of ADHD increases the risk for SUD in ADHD patients but follow-up studies suggest treatment protects patients from subsequent SUDs. This report uses retrospective data to assess the impact of prior ADHD pharmacotherapy on SUDs in 206 ADHD adults (n=79 late-onset ADHD, n=127 full ADHD) grouped by lifetime history of ADHD treatment (no treatment, past treatment, current and past treatment).Method: Structured Clinical Interview for DSM-IV (SCID) data were used to establish abuse and dependence, and Drug Use Screening Inventory (DUSI) responses were used to establish prevalence of use, preference for cigarettes, alcohol and drugs of abuse, complications from use, and motivation for use (get high, change mood, sleep better).Results: No differences were found in the prevalence of cigarette smoking, alcohol or drug abuse or dependence, as well as no significant differences in 1-month prevalence of any use or use more than 20 times. No differences were found in complications of drug or alcohol use across groups. Subjects with current treatment rated getting high as a motivating factor significantly more frequently than subjects in the past treatment group; this result lost significance when we included ADHD diagnostic category.Conclusions: Our results are consistent across substances and ADHD diagnoses, and support the hypothesis that pharmacotherapy does not cause subsequent SUDs.
- 2 January 2007
- Published by Wiley in The American Journal on Addictions
- Vol. 16 (s1) , 14-23
Do Individuals with ADHD Self‐Medicate with Cigarettes and Substances of Abuse? Results from a Controlled Family Study of ADHD
Studies report increased rates of cigarette and substance use in youths with Attention‐Deficit/Hyperactivity Disorder (ADHD), though the mechanism of risk remains unclear. The present study tests the hypothesis that ADHD individuals “self‐medicate” with cigarettes and substances of abuse. As part of five‐ and ten‐year case‐control longitudinal family studies of ADHD, responses to the Drug Use Screening Inventory (DUSI) were examined for evidence of self‐medication. DUSI data from 90 ADHD probands and 96 control probands were obtained. Thirty‐six percent of subjects reported self‐medication, 25% used to get high, and 39% had unknown motivation. No significant differences were found between ADHD and controls in motivation. ADHD symptoms did not differ between self‐medicators and subjects using to get high. DUSI problem scores were higher in ADHD (versus controls), those using to get high (versus self‐medicators), and subjects using alcohol (versus other substances). More than one‐third of adolescents and young adults endorsed using cigarettes and substances for self‐medication. Studies clarifying the role of self‐medication in substance use disorders are necessary.
- 2 January 2007
- Published by Wiley in The American Journal on Addictions
- Vol. 16 (s1) , 14-23
Do Individuals with ADHD Self‐Medicate with Cigarettes and Substances of Abuse? Results from a Controlled Family Study of ADHD
Studies report increased rates of cigarette and substance use in youths with Attention‐Deficit/Hyperactivity Disorder (ADHD), though the mechanism of risk remains unclear. The present study tests the hypothesis that ADHD individuals “self‐medicate” with cigarettes and substances of abuse. As part of five‐ and ten‐year case‐control longitudinal family studies of ADHD, responses to the Drug Use Screening Inventory (DUSI) were examined for evidence of self‐medication. DUSI data from 90 ADHD probands and 96 control probands were obtained. Thirty‐six percent of subjects reported self‐medication, 25% used to get high, and 39% had unknown motivation. No significant differences were found between ADHD and controls in motivation. ADHD symptoms did not differ between self‐medicators and subjects using to get high. DUSI problem scores were higher in ADHD (versus controls), those using to get high (versus self‐medicators), and subjects using alcohol (versus other substances). More than one‐third of adolescents and young adults endorsed using cigarettes and substances for self‐medication. Studies clarifying the role of self‐medication in substance use disorders are necessary.